Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Journal of Immunological Methods|May 20, 1987
Antibody recognition of substituted ammonium ions. Modulation by the counterionM Pallardy, G F Alberici, A Goodman, et al.Gene Therapy|October 19, 2005
Gene therapy bio-safety: scientific and regulatory issuesP Gonin, C J Buchholz, M Pallardy, et al.European Journal of Immunology|December 1, 1996
Interleukin-10 and interleukin-4 have similar effects on hapten-specific primary antibody responses to penicillin in vivoS Kerdine, M Pallardy, S Lamanètre, et al.Toxicology|November 1, 1994
Immune parameters are affected differently after cyclosporine A exposure in Fischer 344 rats and B6C3F1 mice: implications for immunotoxicologyC Blot, H Lebrec, R Roger, et al.International Journal of Immunopharmacology|January 1, 1987
Polyclonal antibodies to elliptinium acetate: structure-activity relationships and comparison with human anti-elliptinium IgMM Pallardy, G F Alberici, J J Dessaux, et al.Food Additives & Contaminants. Part B, Surveillance|May 3, 2014
Monitoring the levels of deoxynivalenol (DON) in cereals in Lebanon and validation of an HPLC/UV detection for the determination of DON in crushed wheat (bulgur)D Antonios, V Guitton, S Darrozes, et al.European Cytokine Network|April 22, 1999
Synergism between interleukin-6 and interleukin-1beta in hypothalamic serotonin release: a reverse in vivo microdialysis study in F344 ratsY Wu, E K Shaghaghi, C Jacquot, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|August 1, 1994
Immunotoxicological investigation using pharmaceutical drugs: in vivo evaluation of immune effectsH Lebrec, C Blot, S Pequet, et al.Cellular Immunology|February 25, 1996
CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosisR Roger, J Bréard, M Comisso, et al.International Journal of Cancer|June 15, 1994
Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon gamma: immunological monitoringF Farace, M Pallardy, E Angevin, et al.Pageof 6